Although the study was conducted at a single center, patients achieved clinical improvement and cessation of steroid therapy.

ALX Oncology (ALXO) announced “encouraging” data from an ongoing Phase 1/2 investigator-sponsored trial of the company’s lead clinical ...

Rituximab, a lower-cost treatment, may be as effective at managing RRMS as the approved therapy Ocrevus, a new study from Egypt suggests.

In a situation where the patient has low tumor burden, but is symptomatic, the approved treatment is rituximab, Strati explained. However, in a scenario where there is high tumor burden and ...

KRISHNAGIRI: A 15-year-old girl from Hosur who has been diagnosed with an autoimmune disease is in need of a critical ...

The prescribed dosage for Rituxan (rituximab) may vary depending on a person’s specific diagnosis and medical history. Your doctor will determine the best dosage of this drug for your condition.

Objective—The TrialNet Study Group evaluated rituximab, a B-cell–depleting monoclonal antibody, for its effect in new-onset patients with type 1A diabetes. Rituximab decreased the loss of C ...

Research shows nearly 20% of patients with pemphigus experience relapse. An additional dose of rituximab in patients with a predictor for relapse reduced the relapse rate (2.6%). Patients with ...

This open-label phase I study enrolled patients 18 years or older with newly diagnosed DLBCL. The first cohort (n = 6) received intravenous rituximab plus CHOP. This cohort received sqR for subsequent ...

The FDA has approved Genentech’s subcutaneous version of the cancer drug rituximab, allowing for a more convenient injection lasting minutes, rather than several hours. Branded as Rituxan Hycela ...

To stabilize this condition we started rituximab therapy immediately after the third cycle of immunoadsorption, with 375 mg/m 2 rituximab being administered intravenously once weekly for 4 weeks.

Celltrion’s biosimilar marketing strategy in Europe has got seriously confusing after the firm asked to market its rituximab near-copy under four different brands. Its biosimilar of Roche’s ...